← Back to Clinical Trials
RecruitingNCT06866522

Light Reflection on Human Skin in Whole-Body Photobiomodulation Therapy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionPhotobiomodulation Therapy
SponsorUniversidade Federal de Sao Carlos
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment72
SexALL
Min Age18 Years
Max Age30 Years
Start Date2023-11-27
Completion2025-03-20
Interventions
Whole-body Photobiomodulation Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Photobiomodulation therapy (PBMT) is based on exposing biological tissues to low-intensity light, with effects depending on the light-tissue interaction. When irradiated without skin contact, part of the incident light is reflected and lost. In this context, the amount of reflected light in PBMT applied without skin contact, as well as the influence of skin phototype, has not yet been established. Objective: To quantify the reflection of light from PBMT on the skin of men and women aged 18 to 30 years, considering skin phototypes. Methodology: Participants will be divided into three groups based on skin phototype (Group 1: phototypes I and II; Group 2: phototypes III and IV; Group 3: phototypes V and VI) and sex. They will be subjected to whole-body PBMT with red light (660 nm; 31.85±3.85 mW; 45.50±5.07 mW/cm²) and infrared light (850 nm; 25.29±2.99 mW; 36.13±4.27 mW/cm²) at 20 cm from the light-emitting source, with measurement of light reflection in the regions of the brachial biceps, abdomen, lumbar, anterior and posterior thigh, and calf using a power and energy analyzer (powermeter PM100D and sensor S130C, 0.7 cm²). Data will be analyzed for normality and groups were compared with a significance level of 5%

Eligibility Criteria

Inclusion Criteria: * male and female * age between 18 and 30 years * body mass index (BMI) between 18.5 and 29.9 kg/m2. Exclusion Criteria: * tattoo in the light reflection assessment areas * history of skin cancer * skin lesions such as open wounds in the mid-thigh, abdomen, biceps brachii, back and calf * patients with cognitive difficulty reporting thermal sensation

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology